PMKIF (PT Merck Tbk) Change In Payables And Accrued Expense : $0.00 Mil (TTM As of Jun. 2024)

View and export this data going back to 2012. Start your Free Trial

What is PT Merck Tbk Change In Payables And Accrued Expense?

PT Merck Tbk's Change In Payables And Accrued Expense for the quarter that ended in Jun. 2024 was $0.00 Mil. It means PT Merck Tbk's Accounts Payable & Accrued Expense stayed the same from Mar. 2024 to Jun. 2024 .

PT Merck Tbk's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was $0.00 Mil. It means PT Merck Tbk's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .

PT Merck Tbk Change In Payables And Accrued Expense Historical Data

The historical data trend for PT Merck Tbk's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Merck Tbk Change In Payables And Accrued Expense Chart

PT Merck Tbk Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

PT Merck Tbk Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

PT Merck Tbk Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

PT Merck Tbk Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of PT Merck Tbk's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Merck Tbk Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Merck Tbk (GREY:PMKIF) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

MERK:Indonesia

Address

Jalan T.B. Simatupang No. 8, Pasar Rebo, Jakarta Timur, IDN, 13760

Website

https://www.merck.co.id

PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia. The company operates in three segments: Biopharma, Consumer Health, and Others. The company offers pharmaceutical and biological prescription medicines to treat cancer, multiple sclerosis, infertility, growth disorders, and cardiovascular and metabolic diseases, as well as chronic diseases.

PT Merck Tbk Headlines

No Headlines